home · filing · 0001477932-24-006996
8-K filed November 8, 2024, 6:59 PM ET
ticker BGLC
CIK 0001737523
regulatory
confidence high
sentiment negative
materiality 0.80
BioNexus Gene Lab receives Nasdaq delisting notice; appeals with compliance plan including reverse stock split
BioNexus Gene Lab Corp
Received delisting notice on Nov 5, 2024 for failing to maintain minimum $1 bid price after two 180-day grace periods ended Nov 4.
Filed appeal on Nov 8, 2024; hearing stays trading suspension pending Panel decision.
Intends to present compliance plan including potential reverse stock split to regain listing compliance.
Appointed Jook Yuen Low as independent director effective Nov 5, assigned to Audit and Nomination committees.
Re-appointed Su-Leng Tan Lee as Secretary and appointed as President; no compensation change.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Role change
Su-Leng Tan Lee
President
BGLC ·
BioNexus Gene Lab Corp
Effective 2024-11-08
Filed November 8, 2024, 6:59 PM ET
Additionally, the Board has re-appointed Mr. Su-Leng Tan Lee as Secretary of the Company and has appointed him as President, effective immediately.
Appointed
Jook Yuen Low
Director
BGLC ·
BioNexus Gene Lab Corp
Effective 2024-11-05
Filed November 8, 2024, 6:59 PM ET
On November 5, 2024, the Board of Directors of the Company appointed Ms. Jook Yuen Low as an independent director to the Board, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Su-Leng Tan Lee was appointed as President at BioNexus Gene Lab Corp.
Action appointed as President
Role President
Exact text from the filing
Additionally, the Board has re-appointed Mr. Su-Leng Tan Lee as Secretary of the Company and has appointed him as President, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jook Yuen Low was appointed as Director at BioNexus Gene Lab Corp.
Action appointed
Role Director
Exact text from the filing
On November 5, 2024, the Board of Directors of the Company appointed Ms. Jook Yuen Low as an independent director to the Board, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001477932-24-006996
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.